Skip to Main Content

Advertisement

Skip Nav Destination

Issues

Cancer Research

Table of Contents


Breaking Insights

Reviews

Author Choice

Cancer Research Highlights

Perspective

Priority Reports

Genome and Epigenome

Molecular Cell Biology

Tumor Biology and Immunology

Author Choice
Author Choice

Pharmacologically targeting the stromal p38MAPK-MK2 pathway limits metastatic breast cancer growth, preserves bone quality, and extends survival.

Author Choice

Translational Science

Convergence and Technologies

Correction

Retraction

Close Modal

or Create an Account

Close Modal
Close Modal